Press Releases

Year 2009

Year 2008

Wockhardt receives US FDA approval for generic version of Augmentin* Suspension     December 04, 2008 Wockhardt launches Midazolam in the US market   Gets US FDA approval for generic version of insomnia drug   November 13, 2008 Wockhardt’s Q3 Results 2008   Sales grow by 25.1% to Rs. 924 crore Operating Profit up by 16.5%   October 21, 2008 Wockhardt gets US FDA nod to market Ceftazidime injections   To launch generic version of broad spectrum antibiotic Fortaz in the US   October 16, 2008 Wockhardt takes huge strides towards In-licensing and collaborative agreements   Signs in-licensing deal with UK based Sinclair Pharma   October 08, 2008 Wockhardt’s Q2 Results 2008   Sales grow by 48.3% to Rs. 935 crore Operating Profit up by 51.6%   July 28, 2008 Wockhardt’s Q1 Results 2008   Sales up by 50% to Rs. 786 crores Operating Profit up by 50%   April 28, 2008 “A HUMANE BUDGET”   Habil Khorakiwala Wockhardt Chairman & FICCI past-President reacts to the Union Budget   February 29, 2008 Wockhardt’s Robust Annual Results   Sales surge by 53% to Rs. 2,653 crore Net Profit soars by 60% to Rs. 386 crore Operating Margin at 24.1% up 90 basis points   February 20, 2008 Wockhardt enters the US market with generic version of Zithromax   Gets US FDA nod to launch generic version of the broad-spectrum antibiotic   February 13, 2008 Wockhardt to restructure its R&D business     January 30, 2008 Wockhardt to launch generic version of anti-depressant Zoloft in the US market   Gets US FDA approval for Sertraline tablets   January 09, 2008 Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US   Gets US FDA nod for Cetirizine, anti-allergic OTC   January 01, 2008

Press Releases Archives Year 2007 Year 2006

Would like to know more about Wockhardt ? Annual Report 2008 Corporate Presentation Chairman’s Letter to Shareowners Investor Update Quarterly Results

For press enquiries about Wockhardt, please contact Daryl Suchitha Associate Vice President - Corporate Relations Wockhardt Limited Wockhardt Towers, Bandra-Kurla Complex, Bandra East, Mumbai 400 051, India. Tel. : + 91 - 22 - 2653 4444.    Extension: 6303 Direct Tel.: + 91 - 22 - 2659 6303 Fax: + 91 - 22 - 2653 4242 Email: daryls@wockhardt.com

Disclaimer:
The company would like to caution that any forward-looking statements or projections made by the company, including those made in the press release announcements, are subject to risks and uncertainties that may cause actual results to differ materially from those projected.